Publication | Open Access
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocol
40
Citations
69
References
2019
Year
Eudra CT 2016-004808-60; NCT03676504; Pre-results.
| Year | Citations | |
|---|---|---|
Page 1
Page 1